Phase II randomized trial of 41.4 Gy vs. 50.4 Gy in neoadjuvant chemoradiotherapy for resectable esophageal cancer
一项针对可切除食管癌的新辅助放化疗的II期随机试验,比较了41.4 Gy与50.4 Gy的放疗剂量。
期刊:Clinical and Translational Radiation Oncology
影响因子:2.7
doi:10.1016/j.ctro.2026.101155
Esmati, Ebrahim; Nazari, Reza; Aqamolaei, Ali; Maddah Safaei, Afsane; Miri, Rouhollah; Shirkhoda, Mohammad; Jalaeefar, Amirmohsen; Salarvand, Samaneh; Aghili, Mahdi; Farhan, Farshid; Mousavi Darzikolaee, Nima; Kolahdouzan, Kasra; Abyaneh, Romina; Ghalehtaki, Reza